pDONR201: Difference between revisions

From EcoliWiki
Jump to navigation Jump to search
imported>Wikientrybot
Move help links into the <above> tag inside templates.
Wameza (talk | contribs)
 
(12 intermediate revisions by 3 users not shown)
Line 1: Line 1:
==At a Glance {{HelpIcon|Help:Plasmid}}==
==At a Glance {{HelpIcon|Help:Plasmid}}==
[[File:pDONR201.jpg|thumb|400px|Right|From: Invitrogen Manual "Gateway pDONR Vectors" vers. E, 27 June 2007, ''25-0531'']]
<protect><!--box uid=63ce1649aab8b3180235b0af7618f667.0.Q46c9dd74ac812-->
<protect><!--box uid=63ce1649aab8b3180235b0af7618f667.0.Q46c9dd74ac812-->
<!--
<!--
Line 7: Line 9:
*  
*  
****************************************************************************************** -->
****************************************************************************************** -->
{|border="2" cellpadding="4" cellspacing="0" style="margin: 1em 1em 1em 0; border: 1px #aaa solid; border-collapse: collapse;" {{Prettytable}} width='30%' align=left
{| {{Prettytable}} width='30%' align=left id="Q46c9dd74ac812"  class=" tableEdit PlasmidTable" 


|-
|-
!align=left {{table heading style}} |Type
!align=left {{table heading style}} |Type
||
||
Cloning
Gateway cloning vector<ref>http://www.invitrogen.com</ref>
|-
|-
!align=left {{table heading style}} |Origin of Replication
!align=left {{table heading style}} |Origin of Replication
Line 20: Line 22:
!align=left {{table heading style}} |Copy #
!align=left {{table heading style}} |Copy #
||
||
So far, not known, but according to Invitrogen's Website, "pDONR201 contains a pUC ori, they replicate less efficiently resulting in lower plasmid yields."
"...[although] pDONR201 contains a pUC ori, they replicate less efficiently resulting in lower plasmid yields."<ref>http://www.invitrogen.com</ref>
|-
|-
!align=left {{table heading style}} |Markers
!align=left {{table heading style}} |Markers
||
||
Kanamycin<BR>
Kanamycin resistance
chloramphenicol
 
Chloramphenicol resistance
|-
|-
!align=left {{table heading style}} |Link to Sequence
!align=left {{table heading style}} |Link to Sequence
||
||
 
[https://www.lablife.org/g?a=seqa&id=vdb%5fg2%2eFZJ4garUQvpEfArcu7qzuYVMSWs%2d%5fsequence%5f8e6f8bfefe0f434511858d7038ae688ab258719c%5f10 LabLife]
|-
|-
!align=left {{table heading style}} |Features
!align=left {{table heading style}} |Features
||
||
<ref>http://www.invitrogen.com</ref>
[http://www.lablife.org/p?a=vdb_view&id=g2.FZJ4garUQvpEfArcu7qzuYVMSWs- LabLife]
|-
|-
!align=left {{table heading style}} |Accession Number
!align=left {{table heading style}} |Accession Number
Line 39: Line 42:




|-class='sortbottom'
|- class="tableEdit_footer"
|[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=63ce1649aab8b3180235b0af7618f667.0.Q46c9dd74ac812&page=112263&pagename={{FULLPAGENAMEE}}&type=1&template=PlasmidTable edit table] ||
|<span class="tableEdit_editLink plainlinks">[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=63ce1649aab8b3180235b0af7618f667.0.Q46c9dd74ac812&page=112263&pagename={{FULLPAGENAMEE}}&type=1&template=PlasmidTable edit table]</span> ||
|}
|}
<!--box uid=63ce1649aab8b3180235b0af7618f667.0.Q46c9dd74ac812--></protect>
<!--box uid=63ce1649aab8b3180235b0af7618f667.0.Q46c9dd74ac812--></protect>
Line 47: Line 50:
<Br clear='all'>
<Br clear='all'>
==Notes==
==Notes==
pDONR201 must be maintained in a ''ccdB'' resistant strain of ''E. coli''.
pDONR201 has been discontinued by Invitrogen.[[User:Siegele|Siegele]] 18:57, 24 August 2011 (UTC)
Click [[File:pDONR201_GenBankFormat.doc]] for a Word document with pDONR201 sequence and location of features in GenBank format.


==History {{HelpIcon|Help:Plasmid}}==
==History {{HelpIcon|Help:Plasmid}}==
Line 52: Line 60:


==Sources {{HelpIcon|Help:Plasmid}}==
==Sources {{HelpIcon|Help:Plasmid}}==
{{PlasmidSources}}
[http://www.lablife.org/p?a=vdb_view&id=g2%2eFZJ4garUQvpEfArcu7qzuYVMSWs%2d Lablife]


==Sequence {{HelpIcon|Help:Plasmid}}==
==Sequence {{HelpIcon|Help:Plasmid}}==
Line 89: Line 97:
  ACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCG
  ACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCG
  GGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTT
  GGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTT
==Images {{HelpIcon|Help:Plasmid}}==
{{PlasmidImage}}


==References==
==References==

Latest revision as of 22:23, 1 September 2011

At a Glance

From: Invitrogen Manual "Gateway pDONR Vectors" vers. E, 27 June 2007, 25-0531
Type

Gateway cloning vector[1]

Origin of Replication

pUC

Copy #

"...[although] pDONR201 contains a pUC ori, they replicate less efficiently resulting in lower plasmid yields."[2]

Markers

Kanamycin resistance

Chloramphenicol resistance

Link to Sequence

LabLife

Features

LabLife

Accession Number





Notes

pDONR201 must be maintained in a ccdB resistant strain of E. coli.

pDONR201 has been discontinued by Invitrogen.Siegele 18:57, 24 August 2011 (UTC)

Click File:pDONR201 GenBankFormat.doc for a Word document with pDONR201 sequence and location of features in GenBank format.

History

You can help EcoliWiki by writing about the history of this plasmid.

Sources

Lablife

Sequence

You can help EcoliWiki by providing database accessions or, if none are available, the sequence of this plasmid.

CTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCTAGCCAGGAAGAGTTTGTAGAAACGCAAAAAGGCCATCCGTCAGGATGGCCTTCTGCTTAGTTTGATGCCTGGCAGTTTATGGCGGGCGTCCTGC
CCGCCACCCTCCGGGCCGTTGCTTCACAACGTTCAAATCCGCTCCCGGCGGATTTGTCCTACTCAGGAGAGCGTTCACCGACAAACAACAGATAAAACGAAAGGCCCAGTCTTCCGACTGAGCCTTTCGTTTTATTTGAT
GCCTGGCAGTTCCCTACTCTCGCGTTAACGCTAGCATGGATCTCGGGCCCCAAATAATGATTTTATTTTGACTGATAGTGACCTGTTCGTTGCAACAAATTGATGAGCAATGCTTTTTTATAATGCCAAGTTTGTACAAA
AAAGCAGAACGAGAAACGTAAAATGATATAAATATCAATATATTAAATTAGATTTTGCATAAAAAACAGACTACATAATACTGTAAAACACAACATATCCAGTCACTATGAATCAACTACTTAGATGGTATTAGTGACCT
GTAGTCGACCGACAGCCTTCCAAATGTTCTTCGGGTGATGCTGCCAACTTAGTCGACCGACAGCCTTCCAAATGTTCTTCTCAAACGGAATCGTCGTATCCAGCCTACTCGCTATTGTCCTCAATGCCGTATTAAATCAT
AAAAAGAAATAAGAAAAAGAGGTGCGAGCCTCTTTTTTGTGTGACAAAATAAAAACATCTACCTATTCATATACGCTAGTGTCATAGTCCTGAAAATCATCTGCATCAAGAACAATTTCACAACTCTTATACTTTTCTCT
TACAAGTCGTTCGGCTTCATCTGGATTTTCAGCCTCTATACTTACTAAACGTGATAAAGTTTCTGTAATTTCTACTGTATCGACCTGCAGACTGGCTGTGTATAAGGGAGCCTGACATTTATATTCCCCAGAACATCAGG
TTAATGGCGTTTTTGATGTCATTTTCGCGGTGGCTGAGATCAGCCACTTCTTCCCCGATAACGGAGACCGGCACACTGGCCATATCGGTGGTCATCATGCGCCAGCTTTCATCCCCGATATGCACCACCGGGTAAAGTTC
ACGGGAGACTTTATCTGACAGCAGACGTGCACTGGCCAGGGGGATCACCATCCGTCGCCCGGGCGTGTCAATAATATCACTCTGTACATCCACAAACAGACGATAACGGCTCTCTCTTTTATAGGTGTAAACCTTAAACT
GCATTTCACCAGTCCCTGTTCTCGTCAGCAAAAGAGCCGTTCATTTCAATAAACCGGGCGACCTCAGCCATCCCTTCCTGATTTTCCGCTTTCCAGCGTTCGGCACGCAGACGACGGGCTTCATTCTGCATGGTTGTGCT
TACCAGACCGGAGATATTGACATCATATATGCCTTGAGCAACTGATAGCTGTCGCTGTCAACTGTCACTGTAATACGCTGCTTCATAGCACACCTCTTTTTGACATACTTCGGGTATACATATCAGTATATATTCTTATA
CCGCAAAAATCAGCGCGCAAATACGCATACTGTTATCTGGCTTTTAGTAAGCCGGATCCACGCGATTACGCCCCGCCCTGCCACTCATCGCAGTACTGTTGTAATTCATTAAGCATTCTGCCGACATGGAAGCCATCACA
GACGGCATGATGAACCTGAATCGCCAGCGGCATCAGCACCTTGTCGCCTTGCGTATAATATTTGCCCATGGTGAAAACGGGGGCGAAGAAGTTGTCCATATTGGCCACGTTTAAATCAAAACTGGTGAAACTCACCCAGG
GATTGGCTGAGACGAAAAACATATTCTCAATAAACCCTTTAGGGAAATAGGCCAGGTTTTCACCGTAACACGCCACATCTTGCGAATATATGTGTAGAAACTGCCGGAAATCGTCGTGGTATTCACTCCAGAGCGATGAA
AACGTTTCAGTTTGCTCATGGAAAACGGTGTAACAAGGGTGAACACTATCCCATATCACCAGCTCACCGTCTTTCATTGCCATACGGAATTCCGGATGAGCATTCATCAGGCGGGCAAGAATGTGAATAAAGGCCGGATA
AAACTTGTGCTTATTTTTCTTTACGGTCTTTAAAAAGGCCGTAATATCCAGCTGAACGGTCTGGTTATAGGTACATTGAGCAACTGACTGAAATGCCTCAAAATGTTCTTTACGATGCCATTGGGATATATCAACGGTGG
TATATCCAGTGATTTTTTTCTCCATTTTAGCTTCCTTAGCTCCTGAAAATCTCGATAACTCAAAAAATACGCCCGGTAGTGATCTTATTTCATTATGGTGAAAGTTGGAACCTCTTACGTGCCGATCAACGTCTCATTTT
CGCCAAAAGTTGGCCCAGGGCTTCCCGGTATCAACAGGGACACCAGGATTTATTTATTCTGCGAAGTGATCTTCCGTCACAGGTATTTATTCGGCGCAAAGTGCGTCGGGTGATGCTGCCAACTTAGTCGACTACAGGTC
ACTAATACCATCTAAGTAGTTGATTCATAGTGACTGGATATGTTGTGTTTTACAGTATTATGTAGTCTGTTTTTTATGCAAAATCTAATTTAATATATTGATATTTATATCATTTTACGTTTCTCGTTCAGCTTTCTTGT
ACAAAGTGGGCATTATAAGAAAGCATTGCTTATCAATTTGTTGCAACGAACAGGTCACTATCAGTCAAAATAAAATCATTATTTGCCATCCAGCTGCAGCTCTGGCCCGTGTCTCAAAATCTCTGATGTTACATTGCACA
AGATAAAAATATATCATCATGAACAATAAAACTGTCTGCTTACATAAACAGTAATACAAGGGGTGTTATGAGCCATATTCAACGGGAAACGTCGAGGCCGCGATTAAATTCCAACATGGATGCTGATTTATATGGGTATA
AATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGCTTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAAC
TGGCTGACGGAATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCCGGAAAAACAGCATTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATAT
TGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAACGGTTTGGTTGATGCGAGTGATTTTG
ATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAACTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGT
TGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAA
ATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTAATCAGAATTGGTTAATTGGTTGTAACACTGGCAGAGCATTACGCTGACTTGACGGGACGGCGCAAGCTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCA
CTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTTT
TTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCT
GCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCT
ACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCG
GGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTT

References